David Radford
Directeur Général chez ANTEOTECH LIMITED
Fortune : 21 881 $ au 30/04/2024
Postes actifs de David Radford
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANTEOTECH LIMITED | Directeur/Membre du Conseil | 04/10/2022 | - |
| Directeur Général | 04/10/2022 | - |
Historique de carrière de David Radford
Anciens postes connus de David Radford
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EPSILON HEALTHCARE LIMITED | Directeur Général | 19/10/2017 | 11/07/2018 |
| BIOXYNE LIMITED | Directeur/Membre du Conseil | 04/04/2012 | 12/12/2012 |
| President | 04/04/2012 | 12/12/2012 | |
| NANOSONICS LIMITED | Directeur/Membre du Conseil | 04/01/2011 | 16/05/2011 |
| Directeur Général | 16/06/2008 | 16/05/2011 | |
| Allvascular Holdings Pty Ltd. | Directeur Général | - | - |
Hunter Immunology Pty Ltd.
 Hunter Immunology Pty Ltd. Medical SpecialtiesHealth Technology Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia. | Directeur/Membre du Conseil | 02/05/2011 | - |
| Directeur Général | 02/05/2011 | - | |
| Investor Relations Contact | 02/05/2011 | - |
Formation de David Radford
| University of the West of England | Undergraduate Degree |
| Australian Graduate School of Management | Masters Business Admin |
Statistiques
Internationale
| Australie | 8 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Executive Officer | 5 |
| Director/Board Member | 4 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| NANOSONICS LIMITED | Health Technology |
| ANTEOTECH LIMITED | Health Technology |
| BIOXYNE LIMITED | Commercial Services |
| EPSILON HEALTHCARE LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Hunter Immunology Pty Ltd.
Hunter Immunology Pty Ltd. Medical SpecialtiesHealth Technology Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia. | Health Technology |
| Allvascular Holdings Pty Ltd. |
- Bourse
- Insiders
- David Radford
- Expérience